[Conclusions] Patients with

GSD type I showed a growth spurt after LT or PCS and caught up growth Doxorubicin 2 years later. Although they did not reach at level of Z-score=0, they overcame the general growth pattern of non-operation group in GSD type I. And we are waiting the result about their final height after following a growth period. The annual m-delta Z-score for height before & after PCS or LT in GSD type I Disclosures: The following people have nothing to disclose: YoungRok Choi, Nam-Joon Yi, Jae Sung Ko, Jin Soo Moon, Tae Yoo, Sukwon Suh, Jeong-moo Lee, Kwang-Woong Lee, Kyung-Suk Suh Background: Posthepatectomy liver failure (PHLF) is a major complication after hepatectomy. As there was no standardized definition, the International Study Group of Liver Surgery (ISGLS) defined PHLF as increased international normalized ratio and hyperbilirubinemia on or after postoperative day 5, and graded its severity based on required clinical management. We evaluated the impact of the ISGLS definition of PHLF on hepatocellular carcinoma (HCC) patients. Methods: ISGLS definition of PHLF was retrospectively assessed with 210 consecutive HCC patients who underwent curative hepatectomy at our facility from January 2005 to December 2010. The median follow-up period after

hepatectomy was 35.2 months. Results: Thirty-nine (18.6%) patients fulfilled the ISGLS definition of PHLF. Mortality, hospital stay, and morbidity excluding PHLF increased with higher grades of PHLF (P < .001). Overall survival (OS) rates at 1, 3, and 5 years in patients with/without Bay 11-7085 Idasanutlin datasheet PHLF were 69.1/93.5, 45.1/72.5, 45.1/57.8%, respectively (P = .002). Recurrence-free survival (RFS) rates at 1, 3, and 5 years in patients with/without PHLF were 40.9/65.9, 15.7/38.3, 15.7/20.3%, respectively (P = .003). Multivariate analysis revealed that PHLF was significantly associated with both OS

(P = .047) and RFS (P = .019). Extent of resection (P < .001), intraoperative blood loss (P = .002), and fibrosis stage (P = .040) were identified as independent risk factors for developing PHLF. Conclusion: The ISGLS definition of PHLF was associated with OS and RFS in HCC patients, and long-term survival will be improved by reducing the incidence of PHLF. Disclosures: The following people have nothing to disclose: Kenji Fukushima, Takumi Fukumoto, Kaori Kuramitsu, Masahiro Kido, Atsushi Takebe, Motofumi Tanaka, Tomoo Itoh, Yonson Ku Adult to adult live donor liver transplantation (LDLT) offers excellent post-LT outcomes and reduces wait-list mortality. However, only a proportion of LT candidates have a potential LD. We hypothesize that potentially modifiable differences exist between LT candidates for whom at least one potential LD steps forward and those for whom not.